These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 977566)

  • 1. Methylisocyanate as an antisickling agent and its reaction with hemoglobin S.
    Lee CK
    J Biol Chem; 1976 Oct; 251(20):6226-31. PubMed ID: 977566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
    Cerami A; Manning JM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1180-3. PubMed ID: 5288366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanate and hemoglobin-S: effect of carbamylation of the alpha and beta chain alpha-amino groups on O2 affinity.
    Rossi F; Perrella M; Bresciani D; Guglielmo G; Rossi-Bernardi L
    FEBS Lett; 1975 Jul; 55(1):99-101. PubMed ID: 237798
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pH, carbamylation and other hemoglobins on deoxyhemoglobin S aggregation inside intact erythrocytes as detected by proton relaxation rate measurements.
    Chuang AH; Waterman MR; Yamaoka K; Cottam L
    Arch Biochem Biophys; 1975 Mar; 167(1):145-50. PubMed ID: 236726
    [No Abstract]   [Full Text] [Related]  

  • 6. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
    Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of the carbamylation kinetics and antisickling mechanism in hemoglobin S blood.
    Uvelli DA; Lee MY; Manning JM; Hlastala MP; Babb AL
    J Lab Clin Med; 1980 May; 95(5):748-58. PubMed ID: 7365317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG; Miller DR; Cerami A; Manning JM
    J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features required for the reactivity and intracellular transport of bis(3,5-dibromosalicyl)fumarate and related anti-sickling compounds that modify hemoglobin S at the 2,3-diphosphoglycerate binding site.
    Chatterjee R; Iwai Y; Walder RY; Walder JA
    J Biol Chem; 1984 Dec; 259(23):14863-73. PubMed ID: 6501320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of action of cyanate in sickle cell disease. Oxygen affinity and gelling properties of hemoglobin S carbamylated on specific chains.
    Nigen AM; Njikam N; Lee CK; Manning JM
    J Biol Chem; 1974 Oct; 249(20):6611-6. PubMed ID: 4421180
    [No Abstract]   [Full Text] [Related]  

  • 11. Antisickling agents: effects of carbamyl phosphate or cyanate on survival, erythrocytes, and leucocytes in the mouse.
    Kraus LM; Jernigan HM; Schrank GD; Kraus AP
    Am J Hematol; 1979; 6(4):343-51. PubMed ID: 532803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
    Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
    J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl acetyl phosphate, a new type of antisickling agent: site-specific acetylating agent toward the 2,3-DPG binding site in hemoglobin S.
    Ueno H; Manning JM
    Am J Pediatr Hematol Oncol; 1988; 10(4):348-50. PubMed ID: 3239714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the carbamylation of the amino groups of sickle cell hemoglobin by cyanate.
    Lee CK; Manning JM
    J Biol Chem; 1973 Aug; 248(16):5861-5. PubMed ID: 4723918
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitors of sickling.
    Mentzer WC
    Am J Pediatr Hematol Oncol; 1982; 4(3):320-7. PubMed ID: 7149171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of cyanate with valine-1 (alpha) of hemoglobin. A probe of conformational change and anion binding.
    Nigen AM; Bass BD; Manning JM
    J Biol Chem; 1976 Dec; 251(23):7638-43. PubMed ID: 1002704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.